Correlation between increased circulating endothelial progenitor cells and stage of non-hodgkin lymphoma

Abstract

This study aims to examine the levels of circulating endothelial progenitor cells (cEPCs) in the peripheral blood of patients with non-Hodgkin lymphoma (NHL) and their correlation with the tumor stage. Forty-one patients with biopsy-proven NHL and 16 healthy individuals were recruited. Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation, and cEPCs were characterized by triple staining using antibodies against CD133, CD34 and vascular endothelial growth factor receptor-2 (VEGFR-2, CD309) and quantified by flow cytometry. In NHL patients, the number of cEPCs was significantly greater than in control group (P=0.000). The cEPCs counts in patients with NHL of stage III-IV were significantly greater than in stage I–II (P=0.010). FACS analysis revealed that the number of cEPCs in NHL patients had no correlation with the gender (P=0.401) or the pathological category (P=0.852). It was suggested that the over-expression of cEPCs in NHL patients may serve as a novel biomarker for disease progression in NHL.

Keywords

circulating endothelial progenitor cells / non-Hodgkin lymphoma / flow cytometry / angiogenesis / biomarker

References

[1] DomeB, HendrixMC, PakuS, et al.. Alternative vascularization mechanisms in cancer. Am J Pathol, 2007, 170(1): 1-15

[2] HoJW, PangRW, LauC, et al.. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology, 2006, 44(4): 836-843

[3] PatenaudeA, ParkerJ, KarsanA. Involvement of endothelial progenitor cells in tumor vascularization. Microvasc Res, 2010, 79(3): 217-223

[4] ShantsilaE, WatsonT, TseHF, et al.. Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?. Ann Med, 2007, 39(6): 474-479

[5] UrbichC, DimmelerS. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res, 2004, 95(4): 343-353

[6] IgrejaC, CourinhaM, CachacoAS, et al.. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica, 2007, 92(4): 469-476

[7] OkiY, YounesA. Endothelial progenitor cells in non-Hodgkin’s lymphoma. Haematologica, 2007, 92(4): 433-434

[8] KhanSS, SolomonMA. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom, 2005, 64(1): 1-8

[9] GrunewaldM, AvrahamI, DorY, et al.. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell, 2006, 124(1): 175-189

[10] AsaharaT, MuroharaT, SullivanA, et al.. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275(5302): 964-967

[11] NowakK, RafatN, BelleS, et al.. Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur J Cardiothorac Surg, 2010, 37(4): 758-763

[12] Richter-EhrensteinC, RentzschJ, RunkelS, et al.. Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Treat, 2007, 106(3): 343-349

[13] MancusoP, ColleoniM, CalleriA, et al.. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood, 2006, 108(2): 452-459

[14] KimHK, SongKS, KimHO, et al.. Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett, 2003, 198(1): 83-88

[15] GoonPK, LipGY, StonelakePS, et al.. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia, 2009, 11(8): 771-779

[16] KermaniP, RafiiD, JinDK, et al.. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest, 2005, 115(3): 653-663

[17] SakamoriY, MasagoK, OhmoriK, et al.. Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancer. Cancer Sci, 2012, 103(6): 1065-1070